Neurocrine Biosciences Dividend
Dividend criteria checks 0/6
Neurocrine Biosciences does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | US$2.48 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Rather Sparingly
Mar 31Neurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional Upside
Feb 11Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) Price In Tune With Earnings
Jan 07Neurocrine Biosciences (NASDAQ:NBIX) Could Easily Take On More Debt
Dec 11Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?
Sep 12We Think Neurocrine Biosciences (NASDAQ:NBIX) Can Manage Its Debt With Ease
Jun 08Neurocrine Biosciences (NASDAQ:NBIX) Has A Rock Solid Balance Sheet
Mar 08Does Neurocrine Biosciences (NASDAQ:NBIX) Have A Healthy Balance Sheet?
Dec 08Neurocrine initiated Equal Weight at Wells Fargo despite upcoming catalysts
Sep 26Neurocrine to acquire U.K.-based biotech Diurnal
Aug 30Sosei to get $30M from Neurocrine as schizophrenia drug gets FDA nod to enter phase 2 trial
Aug 05Neurocrine Biosciences (NASDAQ:NBIX) Seems To Use Debt Quite Sensibly
Jul 26Better Ingrezza Sales And A Clinical Trial Read-Out Could Reignite Neurocrine Shares
Jul 19Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if NBIX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NBIX's dividend payments have been increasing.
Dividend Yield vs Market
Neurocrine Biosciences Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NBIX) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.9% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (NBIX) | 0% |
Notable Dividend: Unable to evaluate NBIX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NBIX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate NBIX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as NBIX has not reported any payouts.